Gabriel Bien-Willner, MD, Pathology, Conroe, TX

GabrielAlejandroBien-WillnerMD

Pathology Conroe, TX

Molecular Genetics, Anatomic Pathology

Chief Medical Officer and MolDX Program Director, Palmetto GBA

Dr. Bien-Willner is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bien-Willner's full profile

Already have an account?

Education & Training

  • Washington University
    Washington UniversityFellowship, Molecular Genetic Pathology, 2011 - 2012
  • Washington University
    Washington UniversityResidency, Anatomic and Clinical Pathology, 2008 - 2011
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2020
  • TX State Medical License
    TX State Medical License 2014 - 2022
  • MO State Medical License
    MO State Medical License 2012 - 2022
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Pathology - Molecular Genetic

Awards, Honors, & Recognition

  • Stowell-Orbison Award US and Canada Association of Pathologists, 2011
  • Young Investigator Award Association of Molecular Pathology, 2012
  • CAP Foundation Scholar CAP Foundation, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors  
    Bien-Willner GA, Mitra RD, Acta Neuropathol Commun, 7/17/2014
  • Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement  
    Bien-Willner, GA, López-Terrada D, Bhattacharjee MB, Patel KU, Stankiewicz P, Lupski JR, Pfeifer JR, Perry A, Neuro-Oncology, 3/13/2012

Lectures

  • Analysis of use of a molecular reporting and treatment decision support tool in more than 1300 cancer cases. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Multidimensional Biomarkers & Machine Learning Based Approaches for Precision Medicine
    Multidimensional Biomarkers & Machine Learning Based Approaches for Precision MedicineOctober 22, 2019 22:29
  • Community Hospitals Can Do Precision Medicine Too - Here's How
    Community Hospitals Can Do Precision Medicine Too - Here's HowMay 19, 2018 16:48

Grant Support

  • American Cancer Society IRGAmerican Cancer Society2013–2014
  • CAP Foundation Research Scholars AwardCAP Foundation2012–2013
  • CAP Foundation Resident Research AwardCAP Foundation2009–2010
  • Pre-Doctoral Intramural Research AwardNational Institutes of Health1999–2000

Professional Memberships